DK203985A - Pyrimidinderivater, deres fremstilling og farmaceutiske anvendelse - Google Patents
Pyrimidinderivater, deres fremstilling og farmaceutiske anvendelse Download PDFInfo
- Publication number
- DK203985A DK203985A DK203985A DK203985A DK203985A DK 203985 A DK203985 A DK 203985A DK 203985 A DK203985 A DK 203985A DK 203985 A DK203985 A DK 203985A DK 203985 A DK203985 A DK 203985A
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- pharmaceutical use
- pyrimidine derivatives
- pyrimidine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848412184A GB8412184D0 (en) | 1984-05-12 | 1984-05-12 | Biologically active nitrogen heterocycles |
| GB858500417A GB8500417D0 (en) | 1985-01-08 | 1985-01-08 | Biologically active nitrogen heterocycles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK203985D0 DK203985D0 (da) | 1985-05-08 |
| DK203985A true DK203985A (da) | 1985-11-13 |
Family
ID=26287736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK203985A DK203985A (da) | 1984-05-12 | 1985-05-08 | Pyrimidinderivater, deres fremstilling og farmaceutiske anvendelse |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0164204A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU4227685A (cg-RX-API-DMAC7.html) |
| DK (1) | DK203985A (cg-RX-API-DMAC7.html) |
| ES (1) | ES8609275A1 (cg-RX-API-DMAC7.html) |
| FI (1) | FI851837A7 (cg-RX-API-DMAC7.html) |
| GR (1) | GR851131B (cg-RX-API-DMAC7.html) |
| IL (1) | IL75147A0 (cg-RX-API-DMAC7.html) |
| NO (1) | NO851877L (cg-RX-API-DMAC7.html) |
| PT (1) | PT80432B (cg-RX-API-DMAC7.html) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4711888A (en) * | 1985-07-24 | 1987-12-08 | Pfizer Inc. | Hydroxy and alkoxy pyrimidines |
| EP0233461B2 (en) † | 1986-01-13 | 2002-05-29 | American Cyanamid Company | 4,5,6-Substituted-2-pyrimidinamines |
| GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
| US5064963A (en) * | 1990-04-25 | 1991-11-12 | American Cyanamid Company | Process for the synthesis of n-(3-(1h-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines |
| JPH06505239A (ja) * | 1991-01-31 | 1994-06-16 | ワーナー−ランバート・コンパニー | 抗炎症剤として有用な４，６−ジ−第三ブチル−５−ヒドロキシ−１，３−ピリミジンの置換されたヘテロアリール類似体 |
| US5248682A (en) * | 1991-01-31 | 1993-09-28 | Warner-Lambert Company | 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| US5270319A (en) * | 1991-09-09 | 1993-12-14 | Warner-Lambert Company | 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents |
| US5220025A (en) * | 1992-02-24 | 1993-06-15 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
| US5196431A (en) * | 1992-02-24 | 1993-03-23 | Warner-Lambert Company | 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents |
| US5276186A (en) * | 1992-03-11 | 1994-01-04 | Ciba-Geigy Corporation | Process for the production of guanidine derivatives |
| US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
| US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
| US5543520A (en) * | 1993-10-01 | 1996-08-06 | Ciba-Geigy Corporation | Pyrimidine derivatives |
| AU693475B2 (en) * | 1993-10-01 | 1998-07-02 | Novartis Ag | Pyrimidineamine derivatives and processes for the preparation thereof |
| ATE208772T1 (de) * | 1993-10-01 | 2001-11-15 | Novartis Erfind Verwalt Gmbh | Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung |
| JP2000506532A (ja) | 1996-03-13 | 2000-05-30 | スミスクライン・ビーチャム・コーポレイション | サイトカイン介在疾患の治療にて有用な新規ピリミジン化合物 |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| CA2401748A1 (en) | 2000-03-29 | 2001-10-04 | Cyclacel Limited | 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| JP2005507420A (ja) * | 2001-11-01 | 2005-03-17 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | グリコーゲン合成酵素キナーゼ３β阻害剤としてのアミノベンズアミド誘導体 |
| IL161662A0 (en) | 2001-11-01 | 2004-09-27 | Janssen Pharmaceutica Nv | Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors (gsk3 inhibitors) |
| AR038368A1 (es) | 2002-02-01 | 2005-01-12 | Novartis Ag | Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento |
| EP1648875A1 (en) | 2003-07-30 | 2006-04-26 | Cyclacel Limited | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| WO2005099688A2 (en) * | 2004-04-07 | 2005-10-27 | Takeda Pharmaceutical Company Limited | Cyclic compounds |
| ES2403558T3 (es) | 2004-08-27 | 2013-05-20 | Cyclacel Limited | Inhibidores purínicos y pirimidínicos de CDK y su uso para el tratamiento de enfermedades autoinmunitarias |
| KR101415426B1 (ko) | 2005-09-27 | 2014-07-04 | 아이알엠 엘엘씨 | 디아릴아민-함유 화합물 및 조성물, 및 ｃ-ｋｉｔ 수용체의조절제로서의 그의 용도 |
| GB0606774D0 (en) * | 2006-04-03 | 2006-05-10 | Novartis Ag | Organic compounds |
| EA017269B1 (ru) | 2007-05-04 | 2012-11-30 | Айрм Ллк | ПРОИЗВОДНЫЕ ПИРИМИДИНА И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ c-kit И PDGFR |
| WO2009026276A1 (en) * | 2007-08-22 | 2009-02-26 | Irm Llc | 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| CA2697077C (en) | 2007-08-22 | 2012-10-16 | Irm Llc | 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| WO2009143183A1 (en) * | 2008-05-19 | 2009-11-26 | University Of Tennessee Research Foundation, The | Pyrimidine non-classical cannabinoid compounds and related methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3496179A (en) * | 1967-10-11 | 1970-02-17 | Pfizer & Co C | 2-amino-3,4-dihydroquinazolines |
| US3635979A (en) * | 1969-09-29 | 1972-01-18 | Pfizer | Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines |
| CA961855A (en) * | 1969-10-16 | 1975-01-28 | Eli Lilly And Company | Immunosuppressants and anti-viral agents |
| US3900476A (en) * | 1973-05-17 | 1975-08-19 | Upjohn Co | 2(2'-pyrimidylamino)quinazolines and their preparation |
| US4010269A (en) * | 1975-06-16 | 1977-03-01 | The Upjohn Company | Antiviral quinazoline compositions and methods of use |
| DE3220118A1 (de) * | 1982-05-28 | 1983-12-01 | Bayer Ag, 5090 Leverkusen | Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1985
- 1985-04-25 EP EP85302902A patent/EP0164204A1/en not_active Withdrawn
- 1985-05-08 DK DK203985A patent/DK203985A/da not_active Application Discontinuation
- 1985-05-09 FI FI851837A patent/FI851837A7/fi not_active Application Discontinuation
- 1985-05-09 GR GR851131A patent/GR851131B/el unknown
- 1985-05-09 IL IL75147A patent/IL75147A0/xx unknown
- 1985-05-10 NO NO851877A patent/NO851877L/no unknown
- 1985-05-10 AU AU42276/85A patent/AU4227685A/en not_active Abandoned
- 1985-05-10 PT PT80432A patent/PT80432B/pt unknown
- 1985-05-10 ES ES543047A patent/ES8609275A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT80432B (en) | 1987-04-16 |
| FI851837L (fi) | 1985-11-13 |
| AU4227685A (en) | 1985-11-14 |
| FI851837A0 (fi) | 1985-05-09 |
| FI851837A7 (fi) | 1985-11-13 |
| DK203985D0 (da) | 1985-05-08 |
| GR851131B (cg-RX-API-DMAC7.html) | 1985-11-25 |
| ES543047A0 (es) | 1986-07-16 |
| EP0164204A1 (en) | 1985-12-11 |
| NO851877L (no) | 1985-11-13 |
| ES8609275A1 (es) | 1986-07-16 |
| PT80432A (en) | 1985-06-01 |
| IL75147A0 (en) | 1985-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK203985D0 (da) | Pyrimidinderivater, deres fremstilling og farmaceutiske anvendelse | |
| DK546186D0 (da) | Substituerede benzylethere, deres fremstilling og anvendelse | |
| DK0426476T3 (da) | Pyrimidinderivater, deres fremstilling og anvendelse | |
| DK595388A (da) | Benzopyranderivater, deres fremstilling og anvendelse | |
| DK193088D0 (da) | 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse | |
| DK274987D0 (da) | Pyrimidin-derivater, deres fremstilling og anvendelse | |
| DK633287A (da) | Carbamoylimidazo-derivater, deres fremstilling og anvendelse | |
| DK28685D0 (da) | Azolyl-aryl-alkanol-derivater, deres fremstilling og anvendelse | |
| DK335286A (da) | 5-substituerede 6-aminopyrimidinderivater, deres fremstilling og anvendelse | |
| DK235787A (da) | Tripeptidderivater, deres fremstilling og anvendelse | |
| DK278188A (da) | Thiazolidin-4-on-derivater, deres fremstilling og anvendelse | |
| DK213387A (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
| DK189488A (da) | Imidazothiadiazinderivater, deres fremstilling og anvendelse | |
| DK548586A (da) | Thienylsulfonylguanidin-derivater, deres fremstilling og anvendelse | |
| DK212687A (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
| DK610787D0 (da) | Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse | |
| DK223288D0 (da) | Benzensulfornamid-derivater, deres fremstilling og anvendelse | |
| DK136985D0 (da) | Sulfamoylguanidin-derivater, deres fremstilling og anvendelse | |
| DK412188D0 (da) | Benzothiazinon-derivater, deres fremstilling og anvendelse | |
| DK361388D0 (da) | Cephemderivater, deres fremstilling og anvendelse | |
| DK136885D0 (da) | Thiatriazin-derivater, deres fremstilling og anvendelse | |
| DK613888A (da) | Acyllabdan-derivater, deres fremstilling og anvendelse | |
| DK668788A (da) | Labdanderivater, deres fremstilling og anvendelse | |
| DK668888A (da) | Labdan-derivater, deres fremstilling og anvendelse | |
| DK136785D0 (da) | Thiatriazin-derivater, deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |